How to buy CONMED Corporation stock | $137.69

CONMED Corporation is a medical devices business based in the US. CONMED Corporation shares (CNMD) are listed on the NYSE and all prices are listed in US Dollars. CONMED Corporation employs 3,400 staff and has a trailing 12-month revenue of around 0.00.

CONMED Corporation stock price (NYSE: CNMD)

Use our graph to track the performance of CNMD stocks over time.

CONMED Corporation shares at a glance

• Key figures

Information last updated 2021-07-29.

Latest market close	$137.69
52-week range	$71.12 - $146.74
50-day moving average	$136.18
200-day moving average	$130.10
Wall St. target price	$157.75
PE ratio	312.3303
Dividend yield	$0.8 (0.58%)
Earnings per share (TTM)	$0.44

Buy CONMED Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy CONMED Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of CONMED Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CONMED Corporation price performance over time

Historical closes compared with the close of $137.69 from 2021-05-28

1 week (2021-07-21)	N/A
1 month (2021-07-01)	-0.77%
3 months (2021-04-30)	-2.31%
6 months (2021-01-28)	N/A

1 year (2020-07-28)	N/A
2 years (2019-07-28)	N/A
3 years (2018-07-28)	N/A
5 years (2016-07-28)	N/A

Is CONMED Corporation under- or over-valued?

Valuing CONMED Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CONMED Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CONMED Corporation's P/E ratio

CONMED Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 312x. In other words, CONMED Corporation shares trade at around 312x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

CONMED Corporation's PEG ratio

CONMED Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.29. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CONMED Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

CONMED Corporation's EBITDA

CONMED Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $142.2 million.

The EBITDA is a measure of a CONMED Corporation's overall financial performance and is widely used to measure a its profitability.

CONMED Corporation financials

Revenue TTM	$881.1 million
Operating margin TTM	8.45%
Gross profit TTM	$477 million
Return on assets TTM	2.66%
Return on equity TTM	1.89%
Profit margin	1.53%
Book value	$24.95
Market capitalisation	$4 billion

TTM: trailing 12 months

Shorting CONMED Corporation shares

There are currently 846,967 CONMED Corporation shares held short by investors – that's known as CONMED Corporation's "short interest". This figure is 17.2% down from 1.0 million last month.

There are a few different ways that this level of interest in shorting CONMED Corporation shares can be evaluated.

CONMED Corporation's "short interest ratio" (SIR)

CONMED Corporation's "short interest ratio" (SIR) is the quantity of CONMED Corporation shares currently shorted divided by the average quantity of CONMED Corporation shares traded daily (recently around 100114.30260047). CONMED Corporation's SIR currently stands at 8.46. In other words for every 100,000 CONMED Corporation shares traded daily on the market, roughly 8460 shares are currently held short.

However CONMED Corporation's short interest can also be evaluated against the total number of CONMED Corporation shares, or, against the total number of tradable CONMED Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CONMED Corporation's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 CONMED Corporation shares in existence, roughly 60 shares are currently held short) or 0.0622% of the tradable shares (for every 100,000 tradable CONMED Corporation shares, roughly 62 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against CONMED Corporation.

Find out more about how you can short CONMED Corporation stock.

CONMED Corporation share dividends

Dividend payout ratio: 35.09% of net profits

Recently CONMED Corporation has paid out, on average, around 35.09% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.58% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CONMED Corporation shareholders could enjoy a 0.58% return on their shares, in the form of dividend payments. In CONMED Corporation's case, that would currently equate to about $0.8 per share.

While CONMED Corporation's payout ratio might seem fairly standard, it's worth remembering that CONMED Corporation may be investing much of the rest of its net profits in future growth.

CONMED Corporation's most recent dividend payout was on 5 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 June 2021 (the "ex-dividend date").

Have CONMED Corporation's shares ever split?

CONMED Corporation's shares were split on a 3:2 basis on 9 September 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your CONMED Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for CONMED Corporation shares which in turn could have impacted CONMED Corporation's share price.

CONMED Corporation share price volatility

Over the last 12 months, CONMED Corporation's shares have ranged in value from as little as $71.1235 up to $146.7354. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CONMED Corporation's is 1.5609. This would suggest that CONMED Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

CONMED Corporation overview

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida. .

Frequently asked questions

What percentage of CONMED Corporation is owned by insiders or institutions?
Currently 0.777% of CONMED Corporation shares are held by insiders and 109.097% by institutions. How many people work for CONMED Corporation?
Latest data suggests 3,400 work at CONMED Corporation. When does the fiscal year end for CONMED Corporation?
CONMED Corporation's fiscal year ends in December. Where is CONMED Corporation based?
CONMED Corporation's address is: 11311 Concept Boulevard, Largo, FL, United States, 33773-4908 What is CONMED Corporation's ISIN number?
CONMED Corporation's international securities identification number is: US2074101013 What is CONMED Corporation's CUSIP number?
CONMED Corporation's Committee on Uniform Securities Identification Procedures number is: 207410101